View Document Preview and Link
Document Date: 2014-07-02 13:50:54 Open Document File Size: 491,74 KB Share Result on Facebook
City Topeka / / Company Amerigroup / / Event Product Issues / FDA Phase / / Facility Landon State Office Building / / / IndustryTerm treatment for cystic fibrosis / / MedicalCondition macular edema / central retinal vein occlusion / chronic pain / severe persistent asthma / macular degeneration / Crohn’s disease / thrombocytopenia / diabetes / hepatitis C / Gaucher disease / ulcerative colitis / pain / cystic fibrosis / active psoriatic arthritis / chronic hepatitis C / asthma / chronic idiopathic urticaria / / MedicalTreatment Enzyme Replacement Therapy / / Organization DUR Board / FDA / Drug Utilization Review Board / / Person F.E. Bustillo / Jennifer Murff / Jonalan Smith / Judy McDaniel Dowd / Lisa Todd / Kelley Melton / Robert Moser / Sam Brownback / Karen Kluczykowski / Roger Unruh / Kevin Waite / Russell Scheffer / John Kollhoff / Nancy Perry / Nicole Ellermeier / Daniel Sutherland / / / Position Governor / Secretary / / Product naloxone / acetaminophen / Cerezyme / Neupogen / Leukine / Testosterone / oxycodone and acetaminophen / Xolair / Demerol / Natesto® / alternative treatment options / / ProvinceOrState Kansas / / Technology genotype / / URL www.kdheks.gov/hcf / / SocialTag